Ufonia Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 18

Ufonia General Information

Description

Developer of an AI-driven voice technology designed to replace routine patient healthcare interactions with automated phone calls. The company's technology offers autonomous, automated, telephone-based clinical follow-up to capture patient-reported outcome measures, enabling healthcare organizations to monitor health and wellness through a conversational voice bot.

Contact Information

Website
www.ufonia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor Percy House
  • 33 Gresse Street
  • London W1T 1QU
  • England, United Kingdom
Primary Industry
Business/Productivity Software
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 2nd Floor Percy House
  • 33 Gresse Street
  • London W1T 1QU
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ufonia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
14. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Later Stage VC 28-Mar-2025 Completed Generating Revenue
11. Accelerator/Incubator 01-Oct-2024 Completed Generating Revenue
10. Seed Round 07-Sep-2022 Completed Generating Revenue
9. Grant 14-Apr-2022 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Angel (individual) 03-Oct-2020 $260K $260K Completed Generating Revenue
6. Grant 08-Sep-2020 $664K Completed Generating Revenue
To view Ufonia’s complete valuation and funding history, request access »

Ufonia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Seed Preferred Shares
Ordinary 1,600 $0.001183 $30.52 $30.52 1x $30.52 1.13%
Ordinary 6,400 $0.001183 $29.57 $29.57 1x $29.57 4.53%
To view Ufonia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ufonia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ufonia Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Propel Healthtech Accelerator/Incubator
Grow London Accelerator/Incubator
Ctrl Group Corporation Minority
Octopus Ventures Venture Capital Minority
Qubit Health Capital Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ufonia FAQs

  • When was Ufonia founded?

    Ufonia was founded in 2017.

  • Where is Ufonia headquartered?

    Ufonia is headquartered in London, United Kingdom.

  • What is the size of Ufonia?

    Ufonia has 44 total employees.

  • What industry is Ufonia in?

    Ufonia’s primary industry is Business/Productivity Software.

  • Is Ufonia a private or public company?

    Ufonia is a Private company.

  • What is Ufonia’s current revenue?

    The current revenue for Ufonia is .

  • How much funding has Ufonia raised over time?

    Ufonia has raised $4.44M.

  • Who are Ufonia’s investors?

    Propel Healthtech, Grow London, Ctrl Group, Octopus Ventures, and Qubit Health Capital are 5 of 18 investors who have invested in Ufonia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process